KINDERHOOK, N.Y.--(BUSINESS WIRE)--American Bio Medica Corporation (NASDAQ: ABMC) announced today that it has successfully completed its previously disclosed private placement of Series A Debentures. ABMC has accepted subscriptions representing a principal amount of $750,000 in Series A Debentures (before deducting fees and expenses related to the placement).